louisakewell, Author at European Medical Journal - Page 97 of 153

Continue
EMJ
1 Mins
28th September 2015

Breakthrough Experimental Therapy Treats Colon Cancer and Chronic Inflammatory Bowel Disease

SCIENTISTS have discovered a groundbreaking experimental therapy that is capable of suppressing the development of ulcerative colitis (UC)…
EMJ
3 Mins
25th September 2015

European CHMP Adopts Positive Opinion for Gilead’s Single Tablet Regimen Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide) for the Treatment of HIV

Foster City, CA, September XX, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP)…
EMJ
5 Mins
24th September 2015

NICE Recommends Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukaemia

London, 24 September 2015 – Gilead Sciences’ Zydelig® (idelalisib) has today been recommended by the National Institute for Health and Care Excellence…
EMJ
1 Mins
21st September 2015

Gout Medications May Be Effective In Treating Alcohol-Induced Liver Disease

COMMONLY used gout medications could offer protection from alcohol-induced liver disease and inflammation, according to the results of new research in mice.
EMJ
1 Mins
21st September 2015

Liver Failure: Stem Cell Therapy Could Replace Liver Transplantation

STEM cell therapy could one day replace liver transplantation as the primary treatment for liver failure, according to a study which saw researchers…
EMJ
2 Mins
15th September 2015

NITID (Optical Coherence Tomography and Digital Dermatoscope Handheld Device) – CE Mark Approval Received

Madrid, September 10, 2015. DermaLumics, a recently founded spin-off of optical tomography systems developer MedLumics, announces that NITID…
EMJ
15th September 2015

Genomic testing for breast cancer in the neoadjuvant setting

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hope S. Rugo, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center…
EMJ
15th September 2015

Introducing the Oncotype DX® Breast Cancer Assay and its impact in clinical practice

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Mohammed Jaloudi, MD, of Tawam Hospital, Al Ain, United Arab Emirates, discusses…
EMJ
15th September 2015

The use of Ki-67, a proliferation marker, for guiding treatment decisions in breast cancer patients

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph Gligorov, MD, PhD, of Sorbonne Université, Paris, France, discusses some…
EMJ
15th September 2015

Introducing the Oncotype DX® Breast Cancer Assay in the clinic

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Harold J. Burstein, MD, PhD, of Dana-Farber Cancer Institute, Boston, MA…